Development of a Family-centred Core Outcome Set for Infants with Developmental Dysplasia of the Hip Treated with a Brace

Overview

Journal Bone Jt Open

Date 2025 Jan 3

PMID 39753147

Authors

Joanna Craven

Olivia OMalley

Daniel C Perry

Affiliations

Soon will be listed here.

Abstract

Aims: This study aims to define a set of family-centred core outcomes for infants undergoing brace treatment to facilitate consistent reporting for future high-quality research.

Methods: Family-centred outcomes will be identified through a literature review and a scoping survey involving key stakeholders, including parents, healthcare professionals, and researchers. These outcomes will then be rated for their perceived importance in a two-stage modified Delphi process with the same stakeholders. Finally, a consensus meeting will be held to establish the final core outcome set (COS).

Conclusion: The impact of brace treatment on the family is profound, but seldom considered in randomized controlled trials. This COS can independently standardize reporting on the family's experience, and potentially become part of a broader COS for developmental dysplasia of the hip in infants undergoing brace treatment.

References

Peters M, Marnie C, Tricco A, Pollock D, Munn Z, Alexander L . Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020; 18(10):2119-2126. DOI: 10.11124/JBIES-20-00167. View

Williamson P, Altman D, Blazeby J, Clarke M, Devane D, Gargon E . Developing core outcome sets for clinical trials: issues to consider. Trials. 2012; 13:132. PMC: 3472231. DOI: 10.1186/1745-6215-13-132. View

Harman N, Bruce I, Kirkham J, Tierney S, Callery P, OBrien K . The Importance of Integration of Stakeholder Views in Core Outcome Set Development: Otitis Media with Effusion in Children with Cleft Palate. PLoS One. 2015; 10(6):e0129514. PMC: 4483230. DOI: 10.1371/journal.pone.0129514. View

Guyatt G, Oxman A, Vist G, Kunz R, Falck-Ytter Y, Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6. PMC: 2335261. DOI: 10.1136/bmj.39489.470347.AD. View

Dwan K, Kirkham J, Paton R, Morley E, Newton A, Perry D . Splinting for the non-operative management of developmental dysplasia of the hip (DDH) in children under six months of age. Cochrane Database Syst Rev. 2022; 10:CD012717. PMC: 9549867. DOI: 10.1002/14651858.CD012717.pub2. View

Altman D, Simera I, Hoey J, Moher D, Schulz K . EQUATOR: reporting guidelines for health research. Lancet. 2008; 371(9619):1149-50. DOI: 10.1016/S0140-6736(08)60505-X. View

Guyatt G, Oxman A, Schunemann H, Tugwell P, Knottnerus A . GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2010; 64(4):380-2. DOI: 10.1016/j.jclinepi.2010.09.011. View

Bradley C, Verma Y, Maddock C, Wedge J, Gargan M, Kelley S . A comprehensive nonoperative treatment protocol for developmental dysplasia of the hip in infants. Bone Joint J. 2023; 105-B(8):935-942. DOI: 10.1302/0301-620X.105B8.BJJ-2023-0149.R1. View

Theunissen W, van der Steen M, van Veen M, van Douveren F, Witlox M, Tolk J . Parental experiences of children with developmental dysplasia of the hip: a qualitative study. BMJ Open. 2022; 12(9):e062585. PMC: 9511546. DOI: 10.1136/bmjopen-2022-062585. View

10.

Cowan K . The James Lind alliance: tackling treatment uncertainties together. J Ambul Care Manage. 2010; 33(3):241-8. DOI: 10.1097/JAC.0b013e3181e62cda. View

11.

Tricco A, Lillie E, Zarin W, OBrien K, Colquhoun H, Levac D . PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Ann Intern Med. 2018; 169(7):467-473. DOI: 10.7326/M18-0850. View

12.

Clarke M . Standardising outcomes for clinical trials and systematic reviews. Trials. 2007; 8:39. PMC: 2169261. DOI: 10.1186/1745-6215-8-39. View

13.

Williamson P, Altman D, Bagley H, Barnes K, Blazeby J, Brookes S . The COMET Handbook: version 1.0. Trials. 2017; 18(Suppl 3):280. PMC: 5499094. DOI: 10.1186/s13063-017-1978-4. View

14.

Schmitt J, Langan S, Stamm T, Williams H . Core outcome domains for controlled trials and clinical recordkeeping in eczema: international multiperspective Delphi consensus process. J Invest Dermatol. 2010; 131(3):623-30. DOI: 10.1038/jid.2010.303. View

15.

Ollivere B, Marson B, Haddad F . Getting the right answer: core outcome sets in orthopaedics. Bone Joint J. 2019; 101-B(3):233-235. DOI: 10.1302/0301-620X.101B3.BJJ-2019-0065. View